Computer Aided Diagnosis in Upper GI Endoscopy
Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 24, 2020
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
5.1 Phase One This phase of the study is non-interventional. It involves two sections: training cohort and validation cohort.
5.1.1 Training Cohort Such artificial intelligence models typically need a lot of data to be fed in, so that it can predict the results with a good accuracy. Since it uses machine learning, the accuracy gets better with each data set that is fed in. For the training cohort, prospective collection of videos on diagnostic OGD would be done. Selected endoscopists would be primed on the examination protocol. Patients would be sedated and given oral N-acetylcysteine 30 m...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients undergoing diagnostic OGD for evaluation of their symptoms
- • 2. Age \>= 18
- Exclusion Criteria:
- • 1. Patients refusing consent/not willing to participate in the study
- • 2. Patients where biopsies cannot or have not been taken
- • 3. Patients with history of gastrectomy
- • 4. Patient admitted for upper gastrointestinal bleeding
- • 5. Patient who are not suitable for EGD examination (such as acute peritonitis with suspected perforated bowel)
- • 6. Pregnant females
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Philip Chiu, MD
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials